InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-22.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Healy James, Director. Director active across 8 companies, notably Natera, Inc.. Aggregated, 41 reports have been published. Breakdown: 6 buys · 4 sells. Total volume traded: €54.9m. Activity tracked since 2 July 2021. The latest transaction was filed on 16 September 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Healy James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
31,603 shares@ US$8.60100.0% of flowCommon StockSEC:0001245624-25-000004:0
25,080 shares0Common StockSEC:0001415889-25-019047:0
142 sharesCommon StockSEC:0001415889-25-011552:0
114 sharesCommon StockSEC:0001415889-25-003070:0
153 sharesCommon StockSEC:0001415889-24-025715:0
1,638,236 sharesCommon StockSEC:0001415889-24-024044:0
177 sharesCommon StockSEC:0001415889-24-020384:0
3,538 shares@ US$23.0755100.0% of flowCommon StockSEC:0001104659-24-077868:0
Canonical exit: 29 Sept 2024 (T+90)
2,964 sharesCommon StockSEC:0001415889-24-019066:0
3,495 shares0Common StockSEC:0001104659-24-071400:0
1,392,738 shares0Common StockSEC:0000950170-24-071532:0
210 sharesCommon StockSEC:0001415889-24-011830:0
32,500 shares@ US$330.0071.7% of flowCommon StockSEC:0001140361-24-013925:0
1,252,308 sharesCommon StockSEC:0001104659-24-008796:0
264 shares@ US$63.790.0% of flowCommon StockSEC:0001415889-24-002000:0
644,000 shares@ US$58.7598.2% of flowCommon StockSEC:0001104659-23-128727:0
396 shares@ US$42.600.0% of flowCommon StockSEC:0001415889-23-014636:0
328 shares@ US$48.480.0% of flowCommon StockSEC:0001415889-23-011687:0
2,750 sharesCommon StockSEC:0001415889-23-010851:0
990 shares0Common StockSEC:0000950170-23-029414:0
400,000 shares0Common StockSEC:0001104659-23-073047:0
2,330 shares0Common StockSEC:0001104659-23-070042:0
3,534 sharesCommon StockSEC:0001415889-23-008925:0
285 shares@ US$54.730.0% of flowCommon StockSEC:0001415889-23-006658:0
6,000 shares@ US$14.320.6% of flowCommon StockSEC:0001209191-23-013481:0
25 of 41 declarations
About Healy James
James Healy is a director with 41 filings in total. Across the 41 sampled filings between 2021-06-02 and 2025-09-18, reported volumes are EUR 18,158,294 of buys and EUR 46,608,499 of sells, with transaction nature listed as Attribution. The companies mentioned in the filings are Natera, Inc., Karuna Therapeutics, Inc., Y-mAbs Therapeutics, Inc., CinCor Pharma, Inc., Rapport Therapeutics, Inc., BioAge Labs, Inc., and Coherus BioSciences, Inc.
